Heart Drug Benefits Type 2 Diabetes
Drug Protects Blood Pressure, Kidneys, and Odds of Survival
May 26, 2004 -- A commonly prescribed high blood pressure medication could prevent early death in people with diabetes.
People with newly diagnosed type 2 diabetes could improve their odds of living longer and improve their heart health by taking these drugs, known as ACE inhibitors, a new study shows.
ACE inhibitors -- or angiotensin-converting enzyme inhibitors -- are used to treat high blood pressure. The drugs work by interfering with the formation of a hormone that can narrow blood vessels and increase blood pressure. Some examples of these medications include the drugs such as Accupril, Monopril, Vasotec, and Zestril.
Over the years, doctors have also prescribed these drugs for patients with type 2 diabetes, explains researcher Jeff Johnson, PhD, an epidemiologist with the University of Alberta in Edmonton, Canada.
His study appears in the June issue of Diabetes Care.
While blood pressure control is important in diabetes, there's also evidence that these drugs protect the kidneys from damage -- another serious complication that results from uncontrolled diabetes, he explains.
People with diabetes are at higher risk for heart disease and early death. But in his study of newly diagnosed people, he shows that these drugs can decrease the risk of death even in people without pre-existing heart disease.
Johnson's study is the first to investigate -- in a large population -- the heart-health benefits of these drugs in people with diabetes.
His finding: ACE inhibitors cutthe risk of death in half, he reports. Also, the drugs reduced the risk of death from heart disease by 23%. "ACE inhibitors reduce [death] risk, whether there is heart disease or not," says Johnson.
5 Years of Evidence
In his study, Johnson and his colleagues analyzed nearly five years worth of medical records of people with newly diagnosed diabetes -- almost 1,200 "new users" of ACE inhibitors and almost 5,000 people with type 2 diabetics not taking ACE inhibitors. The volunteers were men and women whose average age was 61 years old.
During the five-year study, researchers found significantly fewer deaths in the people with type 2 diabetes on ACE inhibitors: